Previous 10 | Next 10 |
MediWound Ltd. (MDWD) Q3 2020 Results Conference Call November 10, 2020 08:30 AM ET Company Participants Jeremy Feffer - IR, LifeSci Advisors Sharon Malka - CEO Boaz Gur-Lavie - CFO Conference Call Participants Ryan Zimmerman - BTIG Raj Denhoy - Jefferies Kevin DeGeeter - Oppenheimer Josh Jen...
MediWound (MDWD): Q3 GAAP EPS of -$0.07 beats by $0.03.Revenue of $6.63M (+29.0% Y/Y) beats by $0.84M.Press Release For further details see: MediWound EPS beats by $0.03, beats on revenue
Total Third Quarter R evenues of $6.6 Million Increased 29 % Y ear-over- Y ear Assigned PDUFA Goal Date of June 29, 2021 for NexoBrid BLA YAVNE, Israel, Nov. 10, 2020 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasd...
YAVNE, Israel, Nov. 02, 2020 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and wound management, today announced that the Company will release its financial results for the ...
MediWound (MDWD) announces the completion of enrollment in a Phase 3 clinical trial evaluating NexoBrid in 145 patients younger than 18 years old with severe burns.The study will compare NexoBrid (concentrate of proteolytic enzymes enriched in Bromelain), a topically administered biologic tha...
YAVNE, Israel, Oct. 28, 2020 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and wound management, today announced it has completed the enrollment stage of its NexoBrid ...
YAVNE, Israel, Oct. 14, 2020 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD) ("MediWound”), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and wound management, today announced that it is exploring the pharmacologica...
Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calendar for companies due to report. Mond...
Pacific Ethanol (PEIX), Great Panther Mining (GPL), and MediWound (MDWD) are three small-cap stocks that have high earnings and revenue growth potential. With a potential rotation from tech to small-caps, these stocks are the likeliest to outperform. Growth has been outperforming value q...
The following slide deck was published by MediWound Ltd. in conjunction with this Read more ...
News, Short Squeeze, Breakout and More Instantly...
Funds to be used for clinical development of EscharEx ® to treat diabetic foot ulcers (DFUs) Award advances MediWound’s DFU program and its future revenues four years ahead of original schedule YAVNE, Israel, July 16, 2024 (GLOBE NEWSWIRE) -- MediWound Ltd....
Mölnlycke® Health Care announces US $15m investment in next-generation enzymatic therapeutics company MediWound Ltd PR Newswire GOTHENBURG, Sweden , July 15, 2024 /PRNewswire/ -- Mölnlycke Health Care, a world-leading MedTech company specialising i...
YAVNE, Israel, July 15, 2024 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), the world leader in next-generation enzymatic therapeutics for tissue repair, today announced it has entered into a definitive share purchase agreement with several new and existing investors, including Mölnlycke...